Zimmer Biomet (ZBH) | Stock Overview & Key Data
Zimmer Biomet Performance Comparison
Stock Range
Today's Range
Low: $94.79
High: $96.32
on July 29, 2025
52 Week Range
Low: $89.22
High: $116.71
on June 3, 2025
on September 3, 2024
All-Time High: $175.11 on April 26, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$19.3B
EPS
4.50
P/E Ratio (TTM)
21.68
Forward P/E
11.34
P/B Ratio
1.56
PEG Ratio
11.34
Div. Yield
1.06%
ROE
7.32%
Beta
0.710
Debt to Equity
59.06
Financial Highlights
Profitability
Gross Margin
71.20%
Operating Margin
17.85%
Profit Margin
11.87%
Returns and Earnings
Return on Assets (TTM)
4.42%
Return on Equity (TTM)
7.32%
EBITDA
$2.5B
Net Income (TTM)
$913.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$38.67
Quarterly Revenue Growth (YoY)
1.10%
Quarterly Earnings Growth (YoY)
5.60%
Dividend Information
Last 12-Month Dividend
$0.96
Current Dividend Yield
1.06%
3-Year Average Dividend Yield
0.21%
3-Year Average Annual Dividend
$0.88
3-Year Total Dividends
$2.64
Ex-Dividend Date
March 31, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Zimmer Biomet ZBH | 19.30B Large-cap | -1.63% | 4.10% | -7.63% | -14.50% | -9.10% | -13.96% | -16.17% | -29.83% |
| Abbott Laboratories ABT | 219.83B Mega-cap | 1.81% | -5.88% | -1.91% | 0.12% | 12.84% | 15.00% | 17.17% | 26.45% |
| Boston Scientific BSX | 157.52B Large-cap | 3.21% | -0.88% | 3.63% | 3.66% | 19.12% | 42.91% | 160.06% | 173.21% |
| Stryker SYK | 154.22B Large-cap | 1.37% | 1.25% | 7.99% | 2.43% | 11.67% | 20.81% | 85.63% | 109.13% |
| Medtronic plc MDT | 118.47B Large-cap | 0.86% | 6.05% | 9.27% | 1.13% | 15.23% | 13.41% | -0.90% | -7.61% |
| Edwards Lifesciences EW | 47.20B Large-cap | 5.47% | 2.89% | 5.49% | 13.13% | 10.86% | 32.29% | -24.17% | 4.59% |
Ownership & Short Interest
Insider Ownership
0.15%
Institutional Ownership
94.61%
Shares Short
7M
Short Ratio
3.32
Short % of Shares Outstanding
4.25%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Zimmer Biomet Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Zimmer Biomet would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ZBH's 52-week high and low?
- In the last 52 weeks, Zimmer Biomet reached a high of $116.71 (on September 3, 2024) and a low of $89.22 (on June 3, 2025).
- What is the market cap and P/E ratio for ZBH?
- Curious about Zimmer Biomet's size and valuation? Its market capitalization stands at 19.30B. When it comes to valuation, the P/E ratio (trailing twelve months) is 21.68, and the forward P/E (looking ahead) is 11.34.
- Does ZBH pay dividends? If so, what's the yield?
- Yes, Zimmer Biomet is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.06%, and the company has paid an average of $0.88 per share annually over the past 3 years.
- Who are Zimmer Biomet's main competitors or similar companies to consider before investing?
When looking at Zimmer Biomet, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT219.83B Healthcare Medical Devices 15.00% 17.17% Boston Scientific
BSX157.52B Healthcare Medical Devices 42.91% 160.06% Stryker
SYK154.22B Healthcare Medical Devices 20.81% 85.63% Medtronic plc
MDT118.47B Healthcare Medical Devices 13.41% -0.90% Edwards Lifesciences
EW47.20B Healthcare Medical Devices 32.29% -24.17% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Zimmer Biomet Holdings, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Zimmer Biomet's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.32%, the Debt to Equity ratio from the most recent quarter is 59.06, and its Gross Profit Margin stands at 71.20%.
- What is the recent revenue and earnings growth for ZBH?
- Looking at Zimmer Biomet's growth, its revenue over the trailing twelve months (TTM) was $8B. Compared to the same quarter last year (YoY), quarterly revenue grew by 1.10%, and quarterly earnings saw a YoY growth of 5.60%.
- How much of ZBH stock is held by insiders and institutions?
- Wondering who owns Zimmer Biomet stock? Company insiders (like executives and directors) hold about 0.15% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 94.61%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.